ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2021
Implementing a prospective surveillance and early intervention model of care for breast cancer-related lymphedema into clinical practice: application of the RE-AIM framework.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 20 citations in OpenAlex.
- The Importance of a Pre-treatment Baseline When Screening Patients for Breast-Cancer-Related Lymphedema.Annals of surgical oncology · 2025Trial
- The effects of early rehabilitation on physical and psychosocial functions after breast cancer surgery.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025Trial
- Axillary Treatment and Chronic Breast Cancer-Related Lymphedema: Implications for Prospective Surveillance and Intervention From a Randomized Controlled Trial.JCO oncology practice · 2023Trial
- Trial
- Article
- Clinician Perspectives on Implementing Breast Cancer-Related Lymphedema Prospective Screening.JAMA network open · 2026Article
- Article
- Article
- Preliminary Efficacy/Feasibility Study of a Breast Cancer-Related Lymphedema Prospective Screening and Early Intervention Program at the Dana-Farber Brigham Cancer Center.Journal of clinical medicine · 2025Article
- The Use of Physiotherapy Navigators in Acute Cancer Care Settings: A Scoping Review.Archives of rehabilitation research and clinical translation · 2025Review
- Reliability of L-Dex Scores for Assessment of Unilateral Breast Cancer-Related Lymphedema.European journal of breast health · 2024Article
- Comparison of Volume Measurements and Bioimpedance Spectroscopy Using A Stand-on Device for Assessment of Unilateral Breast Cancer-Related Lymphedema.European journal of breast health · 2024Article
- Comprehensive strategies in breast cancer-related lymphedema prevention: insights from a multifaceted program.Frontiers in oncology · 2024Article
- Advances in the prevention and treatment of breast cancer-related lymphedema.Breast cancer research and treatment · 2023Review
- Bioimpedance spectroscopy for breast cancer-related lymphedema assessment: clinical practice guidelines.Breast cancer research and treatment · 2023Review
- Article
- A COVID-19 Rehabilitation Prospective Surveillance Model for Use by Physiotherapists.Journal of clinical medicine · 2021Article
- Comment on: 'Increases in arm volume predict lymphoedema and quality of life deficits after axillary surgery: a prospective cohort study.'British journal of cancer · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 4 institutions in 2 countries.
Funding
Abstract
purposeChronic lymphedema following breast cancer (BC) affects individuals physically, functionally, psychologically, and financially. Despite national guidelines and evidence-based research supporting a prospective surveillance and early intervention model of care (PSM), bridging the gap between research and clinical practice has been difficult.
methodAs part of an international randomized controlled trial (RCT), Australian women with BC from four hospitals were recruited, monitored for lymphedema at regular intervals over a 3-year period, and were provided a compression garment if intervention was triggered. The reach, effectiveness, adoption, implementation and maintenance (RE-AIM) evaluation framework was used retrospectively to assess a PSM at the individual and organizational level for those who had completed at least 2-year follow-up (N = 219) in the RCT.
resultsThe application of the RE-AIM framework retrospectively demonstrated an extensive reach to patients across public and private settings; the effectiveness of prospective surveillance and early intervention was achieved through low progression rates to clinical lymphedema (1.8%), and all hospital sites initially approached adopted the research study. Key implementation strategies necessary for effectiveness of this model of care included education to health professionals and patients, staff acceptability, and development of a referral and care pathway. Maintenance dimensions were evaluated both at the individual level with 92-100% adherence rates for all nonoptional study appointments over the 2-year period, and at the organizational-level, PSM was sustained after recruitment ceased for the research study.
conclusionThe PSM for lymphedema in BC can be successfully implemented using the RE-AIM framework applied retrospectively. The implementation of the PSM used in the RCT has assisted in changing clinical practices and improving the quality and effectiveness of the health care system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.